TheraRadar

Pharma Intelligence, Simplified

Landscape → Women's Health

Menopause

130 clinical trials

44 active
/
130 total (since 2015)
6
Phase 1 Active
22 total
17
Phase 2 Active
52 total
13
Phase 3 Active
32 total
15
Phase 4 Active
35 total

Top Sponsors (Industry)

Sorted by active Active Done Failed
Astellas Pharma Global Development, Inc. 2 4 0
Bayer 1 11 0
Astellas Pharma Inc 1 2 0
AbCellera Biologics Inc. 1 0 0
Stratpharma AG 1 0 0
Azure Biotech Inc. 1 0 0
Nyree Penn 1 0 0
Biolab Sanus Farmaceutica 1 0 0
Estetra 0 4 0
NCT06206421 ACTIVE NOT RECRUITING
A Study to Assess Long-term Safety of Fezolinetant Given to Japanese Women Going Through Menopause
Astellas Pharma Inc n=277
NCT06440967 RECRUITING
A Study to Confirm if Fezolinetant Helps Reduce Hot Flashes in Women With Breast Cancer Who Are Having Hormone Therapy
Astellas Pharma Global Development, Inc. n=540
NCT06975111 NOT YET RECRUITING
Focusing on the Menopausal Transition to Improve Mid-Life Women's Health
University of Colorado, Denver n=200
NCT05587296 ACTIVE NOT RECRUITING
A Study to Learn More About How Well Elinzanetant Works and How Safe it is Compared to Placebo for the Treatment of Hot Flashes Caused by Anti-cancer Therapy in Women With, or at High Risk for Developing Hormone-receptor Positive Breast Cancer
Bayer n=474
NCT06343870 RECRUITING
Estradiol and Testosterone Subdermal Implants for Menopause Treatment (ESTIME)
University of Sao Paulo General Hospital n=140
NCT06391372 ACTIVE NOT RECRUITING
Effect of Local Estriol Treatment Before Vaginal Repair Surgery
Hatice Tukenmez Kurnaz n=36
NCT03916978 RECRUITING
Autologous PRP Intra Ovarian Infusion to Restore Ovarian Function in Menopausal Women
Genesis Athens Clinic n=100
NCT04031456 RECRUITING
Autologous PRP Infusion May Restore Ovarian Function and May Promote Folliculogenesis in POI Patients
Genesis Athens Clinic n=100
NCT06564883 NOT YET RECRUITING
Hydration and Acceptability of the Genital and Skin Mucosa of a Vaginal Moisturizer in Menopausal Women
Biolab Sanus Farmaceutica n=45
NCT06530459 RECRUITING
The MUSE Study for Menopausal Arthralgia
National University Hospital, Singapore n=100
NCT06514586 NOT YET RECRUITING
The Efficacy of Topical Vaginal Oxytocin Gel in Postmenopausal Women With Vulvovaginal Atrophy
Oxagon n=244
NCT05586724 RECRUITING
Micronized Progesterone Versus Norethisterone Acetate in Combination With Estrogen as Menopausal Hormone Therapy
Angelica Lindén Hirschberg n=520
NCT06220266 RECRUITING
Effects of Phytoestrogen From Pueraria Mirifica in Improvement of Serum Lipid Parameters in Postmenopausal Women
Dhurakij Pundit University n=10
NCT05042362 COMPLETED
A Study to Learn More About How Well Elinzanetant Works and How Safe it is for the Treatment of Vasomotor Symptoms (Hot Flashes) That Are Caused by Hormonal Changes Over 26 Weeks in Women Who Have Been Through the Menopause
Bayer n=396
NCT05099159 COMPLETED
A Study to Learn More About How Well Elinzanetant Works and How Safe it is for the Treatment of Vasomotor Symptoms (Hot Flashes) That Are Caused by Hormonal Changes Over 26 Weeks in Women Who Have Been Through the Menopause (OASIS-2)
Bayer n=400
NCT04090957 COMPLETED
Estetrol for the Treatment of Moderate to Severe Vasomotor Symptoms in Postmenopausal Women (E4Comfort II)
Estetra n=1,015
NCT06206408 COMPLETED
A Study to Confirm if Fezolinetant Helps Reduce Hot Flashes in Japanese Women Going Through Menopause
Astellas Pharma Inc n=410
NCT05030584 COMPLETED
A Study to Learn More About How Well Elinzanetant Works and How Safe it is for the Treatment of Vasomotor Symptoms (Hot Flashes) That Are Caused by Hormonal Changes Over 52 Weeks in Women Who Have Been Through the Menopause
Bayer n=628
NCT04451226 COMPLETED
A Study to Assess the Safety and Tolerability of Fezolinetant in Women Seeking Treatment for Relief of Vasomotor Symptoms (VMS) Associated With Menopause
Astellas Pharma China, Inc. n=150
NCT04234204 COMPLETED
A Study to Find Out if Fezolinetant Helps Reduce Moderate to Severe Hot Flashes in Women in Asia Going Through Menopause
Astellas Pharma China, Inc. n=302
NCT04209543 COMPLETED
Estetrol for the Treatment of Moderate to Severe Vasomotor Symptoms in Postmenopausal Women (E4Comfort Study I)
Estetra n=1,570
NCT04003142 COMPLETED
A Study to Find Out if Fezolinetant Helps Reduce Moderate to Severe Hot Flashes in Women Going Through Menopause - 2
Astellas Pharma Global Development, Inc. n=501
NCT04003389 COMPLETED
A Study to Find Out How Safe Long-term Treatment With Fezolinetant is in Women With Hot Flashes Going Through Menopause
Astellas Pharma Global Development, Inc. n=1,831
NCT04003155 COMPLETED
A Study to Find Out if Fezolinetant Helps Reduce Moderate to Severe Hot Flashes in Women Going Through Menopause
Astellas Pharma Global Development, Inc. n=527
NCT04026880 WITHDRAWN
Testosterone Effects on Pelvic Floor Muscles
Brigham and Women's Hospital
NCT03854396 WITHDRAWN
Clinical Trial on the Preventive Effect of Intravaginal Prasterone on Recurrent Urinary Tract Infections in Postmenopausal Women
Olivia Cardenas-Trowers, M.D.
NCT02779582 COMPLETED
Oral Micronized Progesterone Effects on Perimenopausal Menstrual Flow
University of British Columbia n=59
NCT02224313 COMPLETED
Effect of Oral Estradiol and Progesterone Therapy on Vaginal Cytokines in Postmenopausal Women
Intira Sriprasert n=20
NCT02961790 COMPLETED
Oxybutynin Chloride in Managing Hot Flashes
Academic and Community Cancer Research United n=150
NCT03202186 TERMINATED
Study of Progesterone in Treatment of Vasomotor Symptoms
BHR Pharma, LLC n=55
NCT02516202 COMPLETED
The Vaginal Health Trial
Fred Hutchinson Cancer Center n=302
NCT02497560 TERMINATED
A Study To Investigate The Effect Of A Natural Dietary Supplement On Peri-Menopausal Symptoms
Physician Recommended Nutriceuticals n=20

Data: ClinicalTrials.gov